header
 

banner rdc

---------------------------------

The Pharmacist e-Link™ Continuing Education Center is designed to provide you with expanded online access to the highest quality of continuing education on a complimentary basis, through the convenience of the Velocity™ Online Learning Management System.


---------------------------------

banner norvasc

---------------------------------

Need Help logging into the Pharmacicst e-Link site?
Click Here for Registration and
Login Information

---------------------------------



banner rdc

This system allows you to search for relevant content from today’s leading providers in the world of continuing education, maintain your personal curriculum, bank your continuing education credits (both online and offline) track and print your professional transcript and more…


bullet Pharmacist e-Link CE Spotlight

thumbnail Bioequivalence, Therapeutic Equivalence, & Clinical Case Management in Thyroid Disease
Studies consistently show that as many as 40% of patients with hypo- or hyper-thyroidism are not well managed by physicians. These studies each used thyroid-stimulating hormone (TSH) as the clinical marker of thyroid dysfunction.
This program is supported by an educational grant from Abbott Laboratories.

thumbnail The Pharmacist's Role in the Medication Therapy Management of Chronic Pain
Managing your patients with chronic pain is critical to ensuring the best patient outcomes. This session will bring you vital information you need to know to give these pharmacy patients the best possible care and greatly improve their quality of life.
This program is supported by an educational grant from Purdue Pharma L.P.

bullet Other Featured CE

thumbnail

The Diagnosis and Management of COPD
According to the American Lung Association, COPD is the fourth leading cause of death in America. This program examines the impact of COPD and disease progression on managed markets in 2005 and focuses on strategies to improve treatment outcomes and effectively coordinate care for the COPD patient.
The program is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.


thumbnail New Approaches and Patient Counseling in the Treatment of Osteoporosis
Osteoporosis will create a significant problem with severe lifestyle impact to one in two women and one in four men over 50 years of age — many of your pharmacy patients. This program brings you insight to treatment of this patient population.
Commercial Support Provided by Roche Laboratories Inc. and GlaxoSmithKline

thumbnail MMA and Injectable Therapies: Impact on Stakeholders, Reimbursement, and Patient Care
This program will feature "in the trenches" players who have prepared for this highly-competitive Medicare drug benefit and shift in market dynamics. It will explain how biologics will be covered and managed under MMA and its clinical outcomes. Faculty will also explore surrounding and reimbursement risks, disabled and dual-eligible patients, and coverage challenges to the employer.
This program is supported by an educational grant from Serono.

thumbnail National Peer Reviews in Cancer Supportive Care: New Directions in Preventing Febrile Neutropenia
This activity is designed to update healthcare professionals on the latest clinical advances in the management of febrile neutropenia.
This program is supported by an educational grant from Amgen.

thumbnail Medication Errors and the Medication Use System: How Do We Improve?
Health care professionals have been trained to "first do no harm" when taking care of patients. The primary components to be discussed include the terminology when identifying events, reporting mechanisms and their effectiveness, the use of data that are reported, and some best practices that all organizations should be addressing.
This program is supported through an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

thumbnail

Emerging Trends in HIV Combination Therapy: The Pharmacology and the Pharmacist
The goal of this CE activity is to proactively engage pharmacists dealing with HIV patients to (1) identify the need for boosted protease inhibitors and other combination therapy (2) recognize areas for increased compliance counseling and (3) communicate any necessary compliance challenges to prescribers will enhance therapeutic outcomes in HIV/AIDS patients.
The program is supported by an educational grant from Roche Laboratories.